Skip to main content

Series A Biotechnology Companies

Explore 772 biotechnology startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
772
Total Funding
$906.5M
Avg Funding
$41.2M
Cities
15

Export 772 Series A Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Francisco, United States
$245.0M
raised

Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.

Oct 2023
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$26.0M
raised

Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.

Oct 2024
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$50.0M
raised

Expedition Medicines develops an AI-powered platform that creates small-molecule drugs for previously inaccessible disease targets.

Oct 2025
Series A

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$10.0M
raised

Odyssey Therapeutics is a computational immunology company that develops novel therapeutics for patients with autoimmune diseases.

Oct 2021
Series A

Founder Contacts

30,000+ verified contacts

Durham, United States
$21.0M
raised

Unlocking human potential with breakthrough mammary biotechnology.

Oct 2021
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Oxford, United Kingdom
$42.0M
raised

Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases

Oct 2022
Series A

Founder Contacts

30,000+ verified contacts

Dresden, Germany
$17.3M
raised

anvajo GmbH is a Dresden-based technology company that develops, manufactures and sells innovative solutions for the analysis of liquids.

Oct 2022
Series A

Founder Contacts

30,000+ verified contacts

Natick, United States
$35.0M
raised

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

Oct 2022
Series A

Founder Contacts

30,000+ verified contacts

Brooklyn, United States
$32.3M
raised

HistoWiz provides automated histopathology for biomedical researchers.

Oct 2021
Series A

Founder Contacts

30,000+ verified contacts

Berkeley, United States
$25.5M
raised

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

Oct 2023
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$22.0M
raised

Empyrean is using genetic engineering to treat severe neuropsychiatric and neurologic illnesses in a way that will revolutionize healthcare.

Oct 2022
Series A

Founder Contacts

30,000+ verified contacts

Vienna, Austria
$8.9M
raised

invIOs is a private biotech company that specializes in the discovery and development of next-generation cancer therapies.

Oct 2024
Series A

Founder Contacts

30,000+ verified contacts

Lyon, France
$30.1M
raised

Mablink Bioscience is a biotechnology company.

Oct 2022
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$70.0M
raised

Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.

Oct 2022
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$100.0M
raised

Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.

Oct 2021
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Palo Alto, United States
$70.0M
raised

Excellergy develops immunology-based therapies focused on treating allergic diseases through novel biologic drug candidates.

Oct 2025
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Carmine Therapeutics develops a novel type of gene therapy that utilizes extracellular vesicles produced in the laboratory.

Oct 2022
Series A

Founder Contacts

30,000+ verified contacts

New Orleans, United States
$3.0M
raised

Obatala Sciences is an assay and research tool development tissue-chip company that specializes in fat-chips.

Oct 2022
Series A

Founder Contacts

30,000+ verified contacts

Boston, United States
$23.4M
raised

Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.

Oct 2025
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom
$18.0M
raised

Supplant is a biotechnology platform that makes sugar substitutes.

Oct 2021
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Singapore, Singapore
$27.0M
raised

AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.

Oct 2021
Series A

Founder Contacts

30,000+ verified contacts

Oxford, United Kingdom
$30.0M
raised

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

Oct 2022
Series A

Founder Contacts

30,000+ verified contacts

Showing 751 to 772 of 772 companies

Ready to Connect with Series A Biotechnology Startups?

Get verified founder emails, funding details, and company data for 772 series a biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

772 Biotechnology Series A Startups (August 2026) — Page 31 | VCBacked